Aveanna Healthcare (NASDAQ:AVAH) Director Rodney Windley Sells 180,000 Shares

Key Points

• Director Rodney Windley sold 180,000 Aveanna Healthcare shares at an average price of $11.50, generating $2.07 million and reducing his ownership by 7.97% to 2,078,017 shares.
• Aveanna’s stock recently traded at $13.70, near its 52-week high of $13.98. The company exceeded quarterly expectations, reporting $0.22 in EPS versus $0.17 expected and revenue of $670.48 million versus $638.61 million estimated.
• Analysts maintain a “Moderate Buy” consensus rating with a $12.89 average price target, while institutional investors own 87.96% of the company’s shares.

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Get Free Report) Director Rodney Windley sold 180,000 shares of the company's stock in a transaction on Thursday, August 20th. The shares were sold at an average price of $11.50, for a total transaction of $2,070,000.00. Following the completion of the transaction, the director owned 2,078,017 shares in the company, valued at approximately $23,897,195.50. This represents a 7.97% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Aveanna Healthcare Stock Performance

AVAH traded up $0.54 on Monday, reaching $13.70. The company had a trading volume of 5,364,375 shares, compared to its average volume of 1,804,109. The stock has a market cap of $2.99 billion, a P/E ratio of 11.14, a P/E/G ratio of 0.92 and a beta of 1.90. The company has a debt-to-equity ratio of 4.47, a quick ratio of 1.16 and a current ratio of 1.16. Aveanna Healthcare Holdings Inc. has a fifty-two week low of $5.93 and a fifty-two week high of $13.98. The company's fifty day moving average is $9.58 and its 200 day moving average is $7.92.

Aveanna Healthcare (NASDAQ:AVAH - Get Free Report) last issued its quarterly earnings data on Thursday, August 13th. The company reported $0.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.05. Aveanna Healthcare had a net margin of 10.56% and a return on equity of 80.70%. The firm had revenue of $670.48 million during the quarter, compared to the consensus estimate of $638.61 million. As a group, analysts predict that Aveanna Healthcare Holdings Inc. will post 0.68 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Aveanna Healthcare

Several institutional investors and hedge funds have recently bought and sold shares of AVAH. Caitong International Asset Management Co. Ltd lifted its holdings in shares of Aveanna Healthcare by 252.4% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company's stock worth $27,000 after acquiring an additional 2,400 shares during the period. C M Bidwell & Associates Ltd. bought a new position in Aveanna Healthcare in the second quarter valued at approximately $69,000. Summit Securities Group LLC bought a new position in Aveanna Healthcare in the first quarter valued at approximately $53,000. Quantbot Technologies LP acquired a new position in Aveanna Healthcare during the second quarter valued at approximately $43,000. Finally, Freestone Grove Partners LP acquired a new position in Aveanna Healthcare during the second quarter valued at approximately $73,000. Institutional investors own 87.96% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages have commented on AVAH. Raymond James Financial upped their price objective on Aveanna Healthcare from $13.00 to $15.00 and gave the company a "strong-buy" rating in a report on Friday, August 14th. Truist Financial lifted their target price on Aveanna Healthcare from $11.00 to $15.00 and gave the stock a "hold" rating in a report on Monday. Wall Street Zen cut shares of Aveanna Healthcare from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 15th. Barclays upped their price target on shares of Aveanna Healthcare from $9.00 to $9.50 and gave the company an "overweight" rating in a research note on Thursday, July 9th. Finally, Stephens upgraded shares of Aveanna Healthcare from an "equal weight" rating to an "overweight" rating and lifted their price objective for the stock from $10.00 to $11.00 in a research note on Friday, May 15th. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $12.89.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc NASDAQ: AVAH is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna's offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source